引用本文:陈 莹,王镇山,薛 欣.阻塞性睡眠呼吸暂停低通气综合征与动脉硬化的相关性[J].大连医科大学学报,2014,36(1):68-72.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
阻塞性睡眠呼吸暂停低通气综合征与动脉硬化的相关性
陈 莹,王镇山,薛 欣
大连医科大学 附属第二医院 呼吸内科,辽宁 大连 116027
摘要:
目的 探讨阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea and hypopnea syndrome,OSAHS)和动脉硬化的关系及纤溶酶原激活物抑制剂-1(plasminogen activator inhibitor-1, PAI-1)在其中的可能机制。方法 根据多导睡眠图(polysomnography, PSG)监测结果分对照组(7例)及OSAHS组(29例),分别检测脉搏传导速度(pulse wave velocity,PWV)、踝臂指数(ankle-brachial index,ABI);酶联免疫吸附法测定血浆PAI-1水平。根据呼吸暂停指数(apnea and hypopnea index, AHI)分对照组(AHI<5次/h)(7例)、轻度OSAHS组(5次/h≤AHI<15次/h)(12例)、中-重度OSAHS组(AHI≥15次/h)(17例),对比3组间动脉硬化阳性率。结果 OSAHS组AHI、PWV、PAI-1均显著高于对照组(均P<0.05);对照组、轻度OSAHS组及中-重度OSAHS组动脉硬化阳性率分别为28.6%、58.3%、82.4%,差异有显著性意义(P=0.048,P<0.05)。(3)双侧ABI与AHI(左r=-0.534,P=0.003,右r=-0.456,P=0.013)均呈负相关。结论 OSAHS增加动脉硬化发生率和动脉硬化的程度,血浆PAI-1在OSAHS患者动脉硬化形成上可能有一定作用。
关键词:  阻塞性睡眠呼吸暂停低通气综合征  动脉硬化  纤溶酶原激活物抑制剂-1
DOI:10.11724/jdmu.2014.01.17
分类号:
基金项目:
Correlation between obstructive sleep apnea and hypopnea syndrome and arterial stiffness
CHEN Ying, WANG Zhen-shan, XUE Xin
Department of Respiratory, the Second Affiliated Hospital of Dalian Medical University, Dalian 116027, China
Abstract:
[Abstract] Objective To analyze the correlation between obstructive sleep apnea and hypopnea syndrome (OSAHS) and arterial stiffness, and explore the possible regulatory role of plasma activator inhibitor-1(PAI-1).Methods Polysomnography (PSG) monitoring were applied to assign cases into control group and OSAHS group. Pulse wave velocity(PWV), ankle-brachial index (ABI) and enzyme-linked immunosorbent assay of PAI-1 were also examined. Based on apnea and hypopnea index (AHI), the subjects were divided into 3 groups, control group (AHI<5), mild group (5≤AHI<15), and moderate-severe group (AHI≥15). Fisher exact test was performed to compare the rate of arterial stiffness among the 3 groups. Results (1) Compared with the control group, AHI, PWV, PAI-1 were significantly higher(P<0.05). (2) Fisher exact test showed that the arterial stiffness positive rates of the control group (n=7), mild OSAHS group (n=12) and moderate-severe OSAHS group (n=17) were 28.6%, 58.3%, and 82.4%, respectively. Significant differences were achieved among these 3 groups (P=0.048, P<0.05). (3) Left and right ABI were negatively correlated with AHI (left r=-0.534, P=0.003; right r=-0.456, P=0.013). Conclusion OSAHS increases the incidence and the degree of arterial stiffness. Plasma PAI-1 may have some effect on arterial stiffness in patients with OSAHS.
Key words:  [Key words] obstructive sleep apnea and hypopnea syndrome  arterial stiffness  plasminogen activator inhibitor-1